P3 Health Partners Inc reports results for the quarter ended in January - Earnings Summary

P3 Health Partners

07/08/2024 23:41

* P3 Health Partners Inc  PIII.OQ  reported a quarterly
adjusted
loss of 9 cents​​ per share for the quarter ended in January,
identical to the same quarter last year.  The mean expectation
of five analysts for the quarter was for a loss of 5 cents per
share. Wall Street expected results to range from -11 cents to 9
cents per share.
    * Revenue rose 15.2% to $379.16 million from a year ago;
analysts
expected $383.47 million. 
    * P3 Health Partners Inc's reported EPS for the quarter was
a loss
of 9 cents​.
    * The company reported a quarterly loss of $12.02 million.
    * P3 Health Partners Inc shares had risen by 34.5% this
quarter and lost 57.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 40% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for P3 Health
Partners Inc is $2.00 
This summary was machine generated from LSEG data August 7 at
10:40 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.05          -0.09          Missed
 Mar. 31 2024      -0.11          -0.16          Missed
 Dec. 31 2023      -0.11          -0.22          Missed
 Sep. 30 2023      -0.22          -0.12          Beat